U.S. market Closed. Opens in 5 hours 32 minutes

ADMA | ADMA Biologics, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for ADMA we got that it has average fundamentals where Valuation is considered to be overvalued, Profitability is moderate, Growth is good and Health is strong.

Valuation (38%)

Company Industry
P/E Ratio (TTM) 60.08 -26.35
PEG Ratio (TTM) 0.64 -7.63
P/S Ratio (TTM) 10.78 45.57
P/B Ratio (TTM) 17.65 32.07
P/FCF Ratio (TTM) 52.10 -9.72
Price to 5YR AVG Earnings Ratio -27.03 -7.44
Price to 5YR AVG FCF Ratio -52.86 -15.00

Profitability (60%)

Company Industry
ROA (TTM) 17.44% -17.05%
ROE (TTM) 38.44% 24.45%
Net Profit Margin (TTM) 17.80% -526.66%
ROIC 5YR AVG -21.41% -6.69%

Growth (63%)

4QTR AVG 3YR AVG 5YR AVG
EPS -124.60% 23.55% 33.98%
Revenue 15.84% 69.45% 73.26%
Net Income -123.73% -12.25% 5.85%
Cash Flow 511.76% -21.87% 19.25%

Health (67%)

Company Industry
Current Ratio (TTM) 7.09 5.80
Quick Ratio (TTM) 3.26 5.58
D/E Ratio (TTM) 0.44 1.15
Interest Coverage (TTM) 6.65 -8.06
Piotroski F-Score 5 4
Altman Z-Score 16.67 13.36
LTL to 5YR AVG FCF -1.80 0.04
Shares Outstanding Growth 5YR AVG 39.15% 39.93%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙